Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel variant with a severe phenotype in a patient with CARD14-associated papulosquamous eruption successfully treated with ixekizumab.

Clinical and experimental dermatology - 21 May 2024

Ouyang Xiaoliang, Zhang Deng, Wang Xiuping, Wu Liang, Xiao Zhen, Zhu Yunxia, Yu Simin, Li Chunming

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Autoimmune Bullous Skin Diseases
Share to CARD Signaling Adaptor Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cutaneous lymphoproliferative disorders research

Share to Dermatologic Agents

Share to Guanylate Cyclase

Share to Membrane Proteins

Share to Phenotype

Source

Identifiers

PMID: 38197442
DOI: 10.1093/ced/llae019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel variant with a severe phenotype in a patient with CARD14-associated papulosquamous eruption successfully treated with ixekizumab.PMID 38197442Read ↗

Clinical response to ustekinumab in CARD14-associated papulosquamous eruption (CAPE) with a new missense mutation in CARD14: a case report and systematic review.Semantic proximity Read ↗

A novel mutation in a CARD14-associated papulosquamous eruption.Semantic proximity Read ↗

CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.Semantic proximity Read ↗

Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14.Semantic proximity Read ↗

Terbinafine-induced generalized pustular psoriasis in a patient carrying CARD14 mutation.Semantic proximity Read ↗

Coexisting mutations in CARD14 and NUDT15 detected in a young female with azathioprine hypersensitivity syndrome manifested as acute generalized exanthematous pustulosis.Semantic proximity Read ↗

Loss-of-function mutations in caspase recruitment domain-containing protein 14 (CARD14) are associated with a severe variant of atopic dermatitisSemantic proximity Read ↗

Germline hypomorphic CARD11 mutations in severe atopic diseaseSemantic proximity Read ↗

Genetic analysis of CARD14 in non-familial pityriasis rubra pilaris: a case series.Semantic proximity Read ↗

Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation.Semantic proximity Read ↗

[Deep dermatophytosis and CARD9-inactivating mutation].Semantic proximity Read ↗

Novel CARD9 mutation in a patient with chronic invasive dermatophyte infection (tinea profunda)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.